Tamsulosin + Finasteride + Placebo
ApprovedUNKNOWN 0 watching 0 views this week๐ฅ Hot
85
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Benign Prostate Hyperplasia
Conditions
Benign Prostate Hyperplasia
Trial Timeline
Feb 1, 2012 โ Jun 1, 2017
NCT ID
NCT01736033About Tamsulosin + Finasteride + Placebo
Tamsulosin + Finasteride + Placebo is a approved stage product being developed by Astellas Pharma for Benign Prostate Hyperplasia. The current trial status is unknown. This product is registered under clinical trial identifier NCT01736033. Target conditions include Benign Prostate Hyperplasia.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01736033 | Approved | UNKNOWN |
Competing Products
20 competing products in Benign Prostate Hyperplasia